Actions
May 8, 2007, 12:00 am ET - Amendment SA 1049 proposed by Senator Brown for Senator Enzi.
May 8, 2007, 12:00 am ET - Amendment SA 1049 as modified agreed to in Senate by Unanimous Consent.
Full Text of this Amendment
SA 1049. Mr. ENZI (for himself and Mr. Kennedy) submitted an amendment intended to be proposed by him to the bill S. 1082, to amend the Federal Food, Drug, and Cosmetic Act to reauthorize and amend the prescription drug user fee provisions, and for other purposes; which was ordered to lie on the table; as follows:
Beginning on page 104, strike line 23 and all that follows through line 14 on page 105 and insert the following:
``(II) the amount equal to one-fifth of the excess amount in item (bb), provided that--
``(aa) the amount of the total appropriation for the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of the total appropriation for the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1); and
``(bb) the amount of the total appropriations for the process of human drug review at the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of appropriations for the process of human drug review at the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1).
In making the adjustment under subclause (II) for any fiscal year 2008 through 2012, subsection (c)(1) shall be applied by substituting `2007' for `2008.' ''.
(As printed in the Congressional Record for the Senate on May 7, 2007.)
Beginning on page 104, strike line 23 and all that follows through line 14 on page 105 and insert the following:
``(II) the amount equal to one-fifth of the excess amount in item (bb), provided that--
``(aa) the amount of the total appropriation for the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of the total appropriation for the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1); and
``(bb) the amount of the total appropriations for the process of human drug review at the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of appropriations for the process of human drug review at the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1).
In making the adjustment under subclause (II) for any fiscal year 2008 through 2012, subsection (c)(1) shall be applied by substituting `2007' for `2008.' ''.
(As printed in the Congressional Record for the Senate on May 7, 2007.)
